BRIGHT MINDS BIOSCIENCES INC.
corporate_fare Company Profile
BRIGHT MINDS BIOSCIENCES INC. (NASDAQ:DRUG) is a publicly traded company in the Life Sciences sector. Wiseek monitors DRUG SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Bright Minds Biosciences Reports Positive Phase 2 BMB-101 Data & Secures $257M Capital for Pipeline Advancement
- Bright Minds Biosciences Closes $175M Public Offering at Premium to Market Price
- Bright Minds Biosciences Secures $175M Public Offering to Fund Clinical Trials
- Bright Minds Biosciences Announces $175M Public Offering to Fund Clinical Trials
- Bright Minds Biosciences Prices Upsized $175M Public Offering at Small Discount
Financial Snapshot
Fiscal year ended September 30, 2025
Net Income
-$12.23M
Op. Cash Flow
-$8.69M
Cash & Equivalents
$55.4M
Debt / Equity
0.00×
Source: 40-F · filed 2025-12-23 · accession 0001437749-25-038729
Insider Transactions
DRUG files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.
show_chartPrice Chart
Loading chart...
feed DRUG - Latest Insights
DRUG
May 19, 2026, 6:15 PM EDT
Price at Filing:
$74.54
Real-time Price:
$60.95
Change:
-$13.59 (-18%)
Market Cap:
$596.527M
DRUG
Jan 09, 2026, 4:11 PM EST
Price at Filing:
$86.75
Real-time Price:
$60.95
Change:
-$25.80 (-30%)
Market Cap:
$596.527M
DRUG
Jan 08, 2026, 7:32 PM EST
Price at Filing:
$90.01
Real-time Price:
$60.95
Change:
-$29.06 (-32%)
Market Cap:
$596.527M
DRUG
Jan 08, 2026, 7:02 PM EST
Price at Filing:
$90.01
Real-time Price:
$60.95
Change:
-$29.06 (-32%)
Market Cap:
$596.527M
DRUG
Jan 07, 2026, 9:37 PM EST
Price at Filing:
$93.48
Real-time Price:
$60.95
Change:
-$32.53 (-35%)
Market Cap:
$596.527M
DRUG
Jan 07, 2026, 5:27 PM EST
Bright Minds Biosciences Terminates Equity Distribution Agreement, Removing Potential Share Overhang
Price at Filing:
$95.00
Real-time Price:
$60.95
Change:
-$34.05 (-36%)
Market Cap:
$596.527M
DRUG
Jan 07, 2026, 3:16 PM EST
Price at Filing:
$95.00
Real-time Price:
$60.95
Change:
-$34.05 (-36%)
Market Cap:
$596.527M
DRUG
Jan 06, 2026, 9:55 PM EST
Price at Filing:
$87.00
Real-time Price:
$60.95
Change:
-$26.05 (-30%)
Market Cap:
$596.527M
DRUG
Jan 06, 2026, 9:54 PM EST
Price at Filing:
$87.00
Real-time Price:
$60.95
Change:
-$26.05 (-30%)
Market Cap:
$596.527M
DRUG
Jan 06, 2026, 7:48 PM EST
Price at Filing:
$87.00
Real-time Price:
$60.95
Change:
-$26.05 (-30%)
Market Cap:
$596.527M
DRUG
Jan 06, 2026, 5:27 PM EST
Price at Filing:
$87.00
Real-time Price:
$60.95
Change:
-$26.05 (-30%)
Market Cap:
$596.527M
DRUG
Jan 05, 2026, 5:26 PM EST
Price at Filing:
$86.75
Real-time Price:
$60.95
Change:
-$25.80 (-30%)
Market Cap:
$596.527M